We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PBPH:NASDAQPortfolio Building Block World Pharma and Biotech Index ETF analysis

Data as of Oct 12, 2026 - not real-time

Latest price
$28.36
Risk: low
3/10Low risk

Summary

The moving-average structure behind Portfolio Building Block World Pharma And Biotech Index ETF is neutral at $28.36, with no clear ordering between short and long averages. The last 30 days have lost 2.4%. Momentum indicators put RSI at 51.1 (neutral) with MACD reading bearish. Recent trading has carved out support near $27.51 and resistance around $28.93.
The 0.13% expense ratio is competitive for its category, and the fund manages $1.05B in assets.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 16.2%, a beta of 0.35 and a maximum drawdown of 11.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 4 out of 10.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 26.56
  • MACD momentum is negative
  • RSI at 51.1 is in neutral territory

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 26.56
  • MACD momentum is negative
  • Low expense ratio of 0.13%

Long term

> 3 years

Neutral

Model confidence4/104 out of 10

Key factors

  • Low expense ratio of 0.13%
  • 30-day volatility of 16.2%
  • Beta of 0.35 versus the benchmark

Key metrics

Fund metrics

Expense Ratio0.13%
AUM$1.0B
Inception Date2025-11-25
Avg Daily Volume97,130
Premium/Discount0.00%
Tracking Error0.00%

Technical analysis

TrendNeutral
RSI51.1
Support$27.51
Resistance$28.93
MA 20$28.31
MA 50$28.37
MA 200$26.56
MACDBearish
VolumeStable
Fear & Greed Index94.93

Risk assessment

Beta0.35
Volatility16.18%
Sector RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.